FindTrial
Sign In

“A Study on the Role of Individualised Homoeopathic Medicines in Regression of Precancerous Cervical Changes among Women in Kanniyakumari District”

Evaluation of effectiveness of individualized homoeopathic medicine in the regression of cervical premalignant lesion of women in kanniyakumari district, a single arm clinical interventional study. - HER-C Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097220
Enrollment
100
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N87- Dysplasia of cervix uteri

Interventions

Intervention1: Interventions-Acid Nitricum, Mercurius solubilus, Calendula Officinalis (Drugs selected according to individuals susceptibility and similimum according to Homoeopathic principles). : In

Sponsors

Ministry of AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Sexualy active women between the age group of 21years to 65 years Patients with cervical intra-epithelial lesion on LBC. Participants willing to provide informed consent

Exclusion criteria

Exclusion criteria: Invasive cancer. HIV positive or immunocompromised. Pregnant/lactating women. Sexually unexposed woman

Design outcomes

Primary

MeasureTime frame
To explore the effect of individualized Homoeopathic medicines on premalignant lesions of the cervix.Timepoint: Baseline: At recruitment (before initiation of treatment). Follow-up 1: At 6 months post-initiation of treatment. Follow-up 2: At 12 months post-initiation of treatment. Final evaluation: At 18 months or end of post intervention follow-up period.—

Secondary

MeasureTime frame
1.To explore specific action of drugs on CIN at different stages. Timepoint: Baseline: At recruitment (before initiation of treatment). Follow-up 1: At 6 months post-initiation of treatment. Follow-up 2: At 12 months post-initiation of treatment. Final evaluation: At 18 months or end of post intervention follow-up period.;2.To explore regression of lesion grade, and HPV status.Timepoint: Baseline: At recruitment (before initiation of treatment). Follow-up 1: At 6 months post-initiation of treatment. Follow-up 2: At 12 months post-initiation of treatment. Final evaluation: At 18 months or end of post intervention follow-up period.—

Countries

India

Contacts

Public ContactDr Girija L

Sarada Krishna Homoeopathic Medical College

gynaehomoeopath@gmail.com9442382082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026